Delivering on the Promise of New Modalities: WuXi AppTec Interview Series

Featured
Parent banner_v2

As part of WuXi AppTec’s ongoing efforts to collaboratively foster new thinking and actionable approaches in advancing breakthroughs for patients, we have launched a new interview series in 2022 – “Delivering on the Promise of New Modalities” – so leading voices of R&D can share how their approaches are addressing the barriers standing in the way of breakthroughs.

Ray Tabibiazar
CEO & Chairman, SalioGen Therapeutics

David Main
President & CEO, Notch Therapeutics

Susan Dillon
CEO, Aro Biotherapeutics

Subscribe to WXPress

Receive our newsletter and information on upcoming events.